rs370724251

Variant names:

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP6_Very_StrongBP7BS1BS2

The NM_004006.3(DMD):c.9486G>A(p.Glu3162Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000146 in 1,209,575 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 61 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., 4 hem., cov: 22)

Exomes 𝑓: 0.00014 ( 0 hom. 57 hem. )

Consequence

DMD
NM_004006.3 synonymous

Scores

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.999

Publications

2 publications found

Variant links:

Genes affected

DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]

DMD Gene-Disease associations (from GenCC):

Becker muscular dystrophy
Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
dilated cardiomyopathy 3B
Inheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
Duchenne and Becker muscular dystrophy
Inheritance: XL Classification: DEFINITIVE Submitted by: Myriad Women’s Health
Duchenne muscular dystrophy
Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
progressive muscular dystrophy
Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
familial isolated dilated cardiomyopathy
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
non-syndromic X-linked intellectual disability
Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers
Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

DMD links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP6

Variant X-31209575-C-T is Benign according to our data. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-31209575-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BP7

Synonymous conserved (PhyloP=0.999 with no splicing effect.

BS1

Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000161 (18/111548) while in subpopulation EAS AF = 0.00392 (14/3570). AF 95% confidence interval is 0.00237. There are 0 homozygotes in GnomAd4. There are 4 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.

BS2

High AC in GnomAd4 at 18 XL,AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
DMD	NM_004006.3 link	c.9486G>A	p.Glu3162Glu	synonymous_variant	Exon 65 of 79	ENST00000357033.9	NP_003997.2	P11532

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
DMD	ENST00000357033.9 link	c.9486G>A	p.Glu3162Glu	synonymous_variant	Exon 65 of 79	1	NM_004006.3	ENSP00000354923.3		A0A075B6G3

Frequencies

GnomAD3 genomes

AF:

0.000161

AC:

AN:

111493

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.0000653

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.0000953

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00391

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.00

Gnomad OTH

AF:

0.000667

GnomAD2 exomes

AF:

0.000218

AC:

AN:

183417

AF XY:

0.000221

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.000109

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00260

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.00

Gnomad OTH exome

AF:

0.000221

GnomAD4 exome

AF:

0.000144

AC:

158

AN:

1098027

Hom.:

Cov.:

AF XY:

0.000157

AC XY:

AN XY:

363387

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

26400

American (AMR)

AF:

0.0000568

AC:

AN:

35207

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

19385

East Asian (EAS)

AF:

0.00281

AC:

AN:

30201

South Asian (SAS)

AF:

0.00

AC:

AN:

54141

European-Finnish (FIN)

AF:

0.00

AC:

AN:

40533

Middle Eastern (MID)

AF:

0.00

AC:

AN:

4135

European-Non Finnish (NFE)

AF:

0.00000238

AC:

AN:

841932

Other (OTH)

AF:

0.00150

AC:

AN:

46093

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.483

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Exome Hom

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.000161

AC:

AN:

111548

Hom.:

Cov.:

AF XY:

0.000119

AC XY:

AN XY:

33752

show subpopulations

African (AFR)

AF:

0.0000652

AC:

AN:

30674

American (AMR)

AF:

0.0000952

AC:

AN:

10501

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

2656

East Asian (EAS)

AF:

0.00392

AC:

AN:

3570

South Asian (SAS)

AF:

0.00

AC:

AN:

2614

European-Finnish (FIN)

AF:

0.00

AC:

AN:

6004

Middle Eastern (MID)

AF:

0.00

AC:

AN:

218

European-Non Finnish (NFE)

AF:

0.00

AC:

AN:

53112

Other (OTH)

AF:

0.000658

AC:

AN:

1519

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.496

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Genome Hom

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.000301

Hom.:

Bravo

AF:

0.000185

ClinVar

Significance: Benign/Likely benign

Submissions summary: Benign:10

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not provided

Benign:4

Jun 22, 2020

GeneDx

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Genome Diagnostics Laboratory, University Medical Center Utrecht

Significance:Likely benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

- -

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen

Significance:Likely benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

- -

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center

Significance:Likely benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

- -

not specified

Benign:2

Jan 22, 2021

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

May 18, 2018

Eurofins Ntd Llc (ga)

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency

Benign:1

Nov 17, 2017

Natera, Inc.

Significance:Likely benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

- -

Dilated cardiomyopathy 3B

Benign:1

Jan 13, 2018

Illumina Laboratory Services, Illumina

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Cardiovascular phenotype

Benign:1

Jan 06, 2016

Ambry Genetics

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Duchenne muscular dystrophy

Benign:1

Jan 27, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.32

CADD

Benign

6.5

(source)

DANN

Uncertain

0.98

PhyloP100

1.0

Mutation Taster

=83/17

polymorphism

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over